A carregar...
Tirosine Kinase Inhibitors Adverse Events
The authors discuss dasatinib as a tyrosine kinase inhibitor with cardiovascular toxicity, which Lenihan and Kowey did not include in their article “Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors.”
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3958466/ https://ncbi.nlm.nih.gov/pubmed/24643716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0397 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|